1. 首页
  2. 细胞
  3. 正文

CPI-1205_1621862-70-1_Absin

产品信息
抗原名称
EZH2 ,EZH1
商品描述

CPI-1205是一种有效的选择性组蛋白赖氨酸甲基转移酶EZH2的抑制剂,具有潜在的抗肿瘤活性。

分子量
518.57
纯度

98% min

可溶性
DMSO 100 mg/mL (192.83 mM)
Ethanol 100 mg/mL (192.83 mM)
Water slightly soluble or insoluble
In vitro(体外研究)
Treatment with EZH2 inhibitor CPI-1205 cause apoptosis in multiple myeloma and plasmacytoma cell models.
In vivo(体内研究)
CPI-1205 shows excellent oral bioavailability. It was well-tolerated for repeat dosing as demonstrated by the absence of significant body weight loss. CPI-1205 shows relatively high clearance in both rats and dogs (3.19 L/h/kg and 1.41 L/h/kg, respectively) but demonstrates good oral bioavailability in both species(44.6% F in rats and 46.2% F in dogs). CPI-1205 was well-tolerated in the 28-day GLP toxicology studies, and any findings were reversible over the recovery period.
背景
别名
CPI 1205, CPI1205
分子式
C27H33F3N4O3
CAS号
1621862-70-1
制备和贮存
保存方式
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.

参考图片

文档下载: W 导出为CPI-1205_1621862-70-1_Absin.doc文档

本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/article/18514.html

(function(){ var src = (document.location.protocol == "http:") ? "http://js.passport.qihucdn.com/11.0.1.js?1d7dde81dc0903e04d3ac0b9599444f6":"https://jspassport.ssl.qhimg.com/11.0.1.js?1d7dde81dc0903e04d3ac0b9599444f6"; document.write('<\/mip-script>'); })(); (function(){ var bp = document.createElement('script'); var curProtocol = window.location.protocol.split(':')[0]; if (curProtocol === 'https') { bp.src = 'https://zz.bdstatic.com/linksubmit/push.js'; } else { bp.src = 'http://push.zhanzhang.baidu.com/push.js'; } var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(bp, s); })();